Thursday, February 23, 2012

Oncogene - Table of Contents alert Volume 31 Issue 8

TABLE OF CONTENTS

Volume 31, Issue 8 (February 2012)

In this issue
Review
Original Articles
short communication

Also new
AOP

Advertisement


Optimal NGS library construction at LIGHTNING speed! Create high-quality genomic libraries for any sequencing platform and achieve successful, cost-efficient next-generation sequencing experiments in 1/5th the time of competing systems. Diagenode's Bioruptor Sonicator is proven as the shearing device of choice providing optimal yields, quality, and fragment size at the industry''s best value. Learn how Diagenode will maximize your sequencing results.
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Nature Reviews Genetics
ANIMATION ON RNA INTERFERENCE

Nature Reviews Genetics, in association with Arkitek Studios, has brought RNAi to life in this vivid, audio-visual journey into the cell.

See RNAi in action by viewing the animation for FREE at: www.nature.com/nrg/multimedia/rnai

Produced with support from
Thermo Scientific
 

Review

Top

The autophagic paradox in cancer therapy

W K K Wu, S B Coffelt, C H Cho, X J Wang, C W Lee, F K L Chan, J Yu and J J Y Sung

Oncogene 2012 31: 939-953; advance online publication, July 18, 2011; 10.1038/onc.2011.295

Abstract | Full Text

Original Articles

Top

Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed human cells

H B Fleisig and J M Y Wong

Oncogene 2012 31: 954-965; advance online publication, July 11, 2011; 10.1038/onc.2011.292

Abstract | Full Text

Dominant-negative mechanism of leukemogenic PAX5 fusions

N Kawamata, M A Pennella, J L Woo, A J Berk and H P Koeffler

Oncogene 2012 31: 966-977; advance online publication, July 18, 2011; 10.1038/onc.2011.291

Abstract | Full Text

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer

E S Martens-Uzunova, S E Jalava, N F Dits, G J L H van Leenders, S Møller, J Trapman, C H Bangma, T Litman, T Visakorpi and G Jenster

Oncogene 2012 31: 978-991; advance online publication, July 18, 2011; 10.1038/onc.2011.304

Abstract | Full Text

Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation

E N Arwert, R A Mentink, R R Driskell, E Hoste, S J Goldie, S Quist and F M Watt

Oncogene 2012 31: 992-1000; advance online publication, July 18, 2011; 10.1038/onc.2011.298

Abstract | Full Text

A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells

G Zhu, Y Wang, B Huang, J Liang, Y Ding, A Xu and W Wu

Oncogene 2012 31: 1001-1012; advance online publication, August 8, 2011; 10.1038/onc.2011.294

Abstract | Full Text

Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells

D Wang, W Ning, D Xie, L Guo and R N DuBois

Oncogene 2012 31: 1013-1023; advance online publication, July 18, 2011; 10.1038/onc.2011.299

Abstract | Full Text

Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs

W Ma, Y Lin, W Xuan, P L Iversen, L J Smith and S Benchimol

Oncogene 2012 31: 1024-1033; advance online publication, July 18, 2011; 10.1038/onc.2011.300

Abstract | Full Text

Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer

K Kim, G Chadalapaka, S-O Lee, D Yamada, X Sastre-Garau, P-A Defossez, Y-Y Park, J-S Lee and S Safe

Oncogene 2012 31: 1034-1044; advance online publication, July 18, 2011; 10.1038/onc.2011.296

Abstract | Full Text

FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells

N McInnes, T J Sadlon, C Y Brown, S Pederson, M Beyer, J L Schultze, S McColl, G J Goodall and S C Barry

Oncogene 2012 31: 1045-1054; advance online publication, July 11, 2011; 10.1038/onc.2011.293

Abstract | Full Text

NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response

Y Zhang, Y Cheng, X Ren, L Zhang, K L Yap, H Wu, R Patel, D Liu, Z-H Qin, I-M Shih and J-M Yang

Oncogene 2012 31: 1055-1064; advance online publication, July 11, 2011; 10.1038/onc.2011.290

Abstract | Full Text

short communication

Top

Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element

J Xu, B Wang, Y Xu, L Sun, W Tian, D Shukla, R Barod, J Grillari, R Grillari-Voglauer, P H Maxwell and M A Esteban

Oncogene 2012 31: 1065-1072; advance online publication, August 15, 2011; 10.1038/onc.2011.305

Abstract | Full Text

Advertisement

Call for papers!

Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function.

Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.

 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: